Company Profiles

driven by the PitchBook Platform

Avectas

Description

Operator of a therapeutics technology company. The company focuses on gene editing and develops technology for delivering proteins, nucleic acids and small or large molecules to the right target without complications associated with viruses and other carriers.

2011

Founded

PRIVATE

Status

Corporate

Latest Deal Type

2

Investors

Description

Operator of a therapeutics technology company. The company focuses on gene editing and develops technology for delivering proteins, nucleic acids and small or large molecules to the right target without complications associated with viruses and other carriers.

Website:

www.avectas.com

Formerly Known As

Profector Life Sciences

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Other Healthcare

Primary Office

34 Fitzwilliam Square Dublin Ireland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avectas's full profile, request a free trial.

    Avectas Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avectas Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Adapt PharmaCorporationMinority000 0000000 0000
    Enterprise IrelandVenture CapitalMinority000 0000000 0000
    Adapt Pharma Corporation
    Enterprise Ireland Venture Capital

    Avectas Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Michael MaguireCo-Founder, President & Chief Executive Officer
    Shirley O'Dea Ph.DCo-Founder & Chief Scientific Officer
    Jim EganChief Medical Officer
    Michael Maguire Co-Founder, President & Chief Executive Officer
    Shirley O'Dea Ph.D Co-Founder & Chief Scientific Officer
    Jim Egan Chief Medical Officer
    Request full access to PitchBook